Iron injection plus radiation for solid tumors
Part of Cancer clinical trials.
This trial tests a new treatment that combines a special iron injection (nano-carbon iron suspension) with standard radiation therapy for solid tumors. The goal is to see if the iron helps the radiation work better, possibly shrinking tumors more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have a type of solid tumor (like soft tissue sarcoma or head and neck cancer) that can be treated with radiation.
- You are able to walk and take care of yourself (ECOG score 0 or 1).
- You have at least one tumor that can be safely injected with the study drug, and that tumor hasn't been treated with radiation before (unless it grew after radiation).
- Your cancer has spread to 5 or fewer spots in the body (oligometastasis).
- Your blood counts, kidney, and liver function are within certain limits, and your heart is working well (LVEF at least 50%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation, focused high-dose radiation, and an immunotherapy drug (tislelizumab) for people with large, advanced solid tumors that have not responded to standard treatments.
This trial tests a new treatment where immune cells (called macrophage exosomes) are injected directly into your tumor to help your body fight the cancer. It's designed for advanced cancers that have not responded to standard treatments.
This trial tests a new treatment for advanced solid tumors that uses tiny iron particles guided by carbon nanoparticles, injected directly into the tumor. It may be an option if standard treatments have stopped working or aren't available, and you have a tumor that can be safely injected.
This trial tests if injecting chemotherapy directly into tumors can help people with advanced solid cancers that have stopped responding to standard treatments. It aims to see how safe and effective this approach is.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests an investigational cell therapy called HS-IT201 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if this treatment can help shrink tumors or slow their growth.
Hear when a new HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.